ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma

Zhang, Huaru; Qiu, Xiaofu; Yang, Guosheng*南方医科大学; 同济大学
Frontiers in Oncology2021-3-31DOI: 10.3389/fonc.2021.620126
3被引11阅读
引用收藏
分享

摘要

The cysteine-serine-rich nuclear protein (CSRNP) family has prognostic value for various cancers. However, the association between this proteins and prognosis of clear cell renal cell carcinoma (ccRCC) remains unclear. This study aimed to determine the prognostic value of the CSRNP family for patients with ccRCC. Therefore, the gene expression profiling interactive analysis database was used to analyze the mRNA expression of CSRNP family members (CSRNPs) in relation with survival. Combined and independent prognostic values of CSRNPs were evaluated using SurvExpress and multivariate Cox regression analyses, respectively. Potential signaling pathways impacted by CSRNPs were evaluated using Metascape. Associations between the CSRNP family and immunocyte infiltration were determined from single-sample gene set enrichment analysis. Both cBioPortal and MethSurv were used to explore whether genomic and epidemic alterations might influence prognosis. We found that when both CSRNP1 and CSRNP3 had a low expression, patients with ccRCC had a worse overall survival (OS). Therefore, a prognostic signature was constructed as follows: risk score = -0.224 x exp(mRNA of) (CSRNP1) + 0.820 x exp(mRNA of) (CSRNP2) - 1.428 x exp(mRNA of) (CSRNP3). We found that OS was worse in patients from the high- than from the low-risk groups (AUC = 0.69). Moreover, this signature was an independent predictor after adjusting for clinical features. Functional enrichment analysis positively associated CSRNPs with the acute inflammatory response and humoral immune response pathways. This was validated by correlating each CSRNP with 28 types of immunocytes in tumor and normal tissues. A higher expression of CSRNP1 and CSRNP3 was associated with a better prognosis in both the high- and low-mutant burden groups. Cg19538674, cg07772537, and cg07811002 of CSRNP1, CSRNP2, and CSRNP3, respectively, were the predominant DNA methylation sites affecting OS. The CSRNP gene family signature may serve as a prognostic biomarker for predicting OS in patients with ccRCC. The association between CSRNPs and immune infiltration might offer future clinical treatment options.

学科与关键词

关键词
clear cell renal cell carcinomaCSRNP familyprognosisimmune infiltrationThe Cancer Genome Atlas (TCGA)
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2021-03-31
卷期
第 11 卷
页码
620126
DOI
10.3389/fonc.2021.620126
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Science and Technology Planning Project of Guangzhou City, Guangdong, China [201904010035]; Natural Science Foundation of Guangdong Province, China [2018A030313905]

作者

  • Z

    Zhang, Huaru (第一作者)

    2 · southern med univ

  • Q

    Qiu, Xiaofu

    2 · southern med univ

查看全部 3 位作者收起作者
  • Y

    Yang, Guosheng (通讯)

    tongji univ · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417